Wikidata

(Q51324403)

English

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study.

scientific article published on 29 April 2014

In more languages

Statements

title
Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24708292
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708292%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51324403&oldid=1202116260"